2TZ Stock Overview
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 5/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥2.04 |
52 Week High | CN¥2.16 |
52 Week Low | CN¥1.96 |
Beta | 0.80 |
1 Month Change | -2.95% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -5.45% |
Recent News & Updates
Recent updates
Shareholder Returns
2TZ | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 3.0% | -2.5% | -2.6% |
1Y | n/a | -15.6% | 6.9% |
Return vs Industry: Insufficient data to determine how 2TZ performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 2TZ performed against the German Market.
Price Volatility
2TZ volatility | |
---|---|
2TZ Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 5.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2TZ's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine 2TZ's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1981 | 4,619 | n/a | www.jydrt.com.cn |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Fundamentals Summary
2TZ fundamental statistics | |
---|---|
Market cap | €2.83b |
Earnings (TTM) | €122.47m |
Revenue (TTM) | €1.06b |
26.6x
P/E Ratio3.1x
P/S RatioIs 2TZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2TZ income statement (TTM) | |
---|---|
Revenue | CN¥8.04b |
Cost of Revenue | CN¥4.30b |
Gross Profit | CN¥3.74b |
Other Expenses | CN¥2.81b |
Earnings | CN¥932.37m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.21 |
Gross Margin | 46.50% |
Net Profit Margin | 11.60% |
Debt/Equity Ratio | 19.8% |
How did 2TZ perform over the long term?
See historical performance and comparisonDividends
4.0%
Current Dividend Yield106%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 12:34 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yalei Yan | Bohai Securities Co., Ltd. |
Chengzhi Chen | CGS International |
Shanshan Li | China Merchants Securities Co. Ltd. |